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The aim of this study was to assess radioprotective effects of quercetin and the ethanolic extract of 
propolis (EEP) in CBA mice exposed to a single radiation dose 4 Gy (60Co). The mice were treated with 
100 mg kg-1 quercetin or EEP a day for three consecutive days either before (pre-treatment) or after 
gamma-irradiation (therapy). Leukocyte count was determined in blood drawn from the tail vein, and 
DNA damage in leukocytes was assessed using the alkaline comet assay. Genotoxic effects of the test 
compunds were also evaluated in non-irradiated mice. The levels of radioprotection provided by both test 
compounds were compared with those established in mice that were given chemical radioprotector S-(2-
Aminoethyl)isothiouronium bromide hydrobromide (AET). Mice that received pre-treatment were less 
sensitive to irradiation. Mice given the post-irradiation therapy showed a slight but not signifi cant increase 
in total leukocyte count over irradiated negative control. Quercetin showed better protective properties than 
EEP in both pre-treatment and therapy, and activated a higher number of leukocytes in non-irradiated mice. 
The alkaline comet assay suggests that both natural compounds, especially when given as pre-treatment, 
protect against primary leukocyte DNA damage in mice. At tested concentrations, EEP and quercetin 
were not genotoxic to non-irradiated mice. AET, however, caused a slight but not signifi cant increase in 
DNA damage. Although the results of this study show the radioprotective potential of the test compounds, 
further investigation is needed to clarify the underlying protection mechanisms.
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Even though a number of substances have been 
studied for radioprotective effects, there is no ideal 
protective strategy to be universally employed in 
occupational and therapeutic settings involving 
exposure to ionising radiation.
Ionising radiation mostly affects DNA, either 
directly or by generating toxic free radicals, and 
induces single strand breaks, double strand breaks, 
oxidative damage to sugar and base residues, 
chromosomal aberrations, and various mutations (1). 
Nevertheless, it is widely applied in the treatment of 
many malignant diseases, but it necessarily involves 
exposure of non-target cells in treated patients.
As radiation effects do not discriminate between 
normal and malignant cells and tissues, investigations 
have been conducted to find effective and non-
toxic radioprotective compounds and to improve 
radiotherapy. Because radiation-induced cell damage 
is primarily attributed to the harmful effects of free 
radicals, molecules with radical scavenging properties 
are particularly promising as radioprotectors (2, 
3). One such compound common to oncological 
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practice is amifostine (S-2-(3-amino-propylamino) 
ethylphosphorothioic acid), but it is expensive, must 
be given intravenously, and has undesirable side 
effects (4).
To overcome harmful effects of synthetic 
compounds, many naturally occurring substances 
have been studied as candidates for effective 
radioprotection. These include polyphenols and 
honeybee products such as propolis and bee venom. 
The awareness of their radioprotective properties has 
increased over the last decade, and their effects have 
extensively been studied in vitro and in vivo (5-12). 
Polyphenols are abundant micronutrients in human diet 
and include hydroxybenzoic acids, hydroxycinnamic 
acids, anthocyanins, proanthocyanidins, fl avonols, 
fl avones, fl avanols, fl avanones, isofl avones, stilbenes, 
and lignans (13). These compounds originate from the 
secondary metabolism of plants and protect against 
photosynthetic stress and reactive oxigen species 
(ROS), and help wounds to heal faster (14). Their 
antioxidant activity is mainly based on their ability 
to scavenge free radicals. They can also enhance 
the function of the endogenous antioxidant enzyme 
systems such as superoxide dismutase, catalase, 
glutathione peroxidase, and glutathione reductase 
(15). These antioxidant effects may also be a result of 
a combination of radical scavenging and interaction 
with enzyme functions (16).
Polyphenol quercetin is a flavonoid abundant 
in fruits, vegetables, olive oil, red wine, tea, and 
propolis. Its daily intake through food is about 16 mg 
(17). It has shown the highest antioxidant potential 
of all fl avonoids (18), but can also produce reactive 
oxigen radicals (19-21). Even though the fi ndings 
about its mutagenicity and toxicity are contradictory, 
the International Agency for Research on Cancer 
(IARC) has not classifi ed quercetin as carcinogenic to 
humans (22). Most harmful effects of quercetin have 
been observed in vitro. It is believed that the absence 
of its carcinogenic effect in vivo is mainly owed to its 
metabolic inactivation after apsorption (23).
Propolis (bee glue) is an adhesive resinous substance 
produced by honey bees from leaf, bud, fl ower, and 
tree sap. The wide variety of its biological properties 
make it ever more interesting for use in medicine. 
Propolis and its active polyphenolic constituents 
have shown antibacterial (24), antioxidant (25), and 
prooxidant properties (26). Propolis also affects 
immunity (27, 28) and acts against cell proliferation 
and tumors in vitro (29) and in vivo (30-33).
Our earlier study showed that both water-soluble 
derivate of propolis (WSDP) and ethanolic extract 
of propolis (EEP) extended the survival of mice 
irradiated with a single lethal dose (9 Gy) of gamma-
irradiation (10). In another study, WSDP and several 
water soluble polyphenols showed radioprotection 
against gamma-irradiation with 4 Gy and 9 Gy (11). 
EEP and quercetin were also confi rmed as useful 
protectors in a study on mice irradiated with 9 Gy 
(12). This study continues our research, and its aim 
was to establish the radioprotective effects of EEP and 
quercetin given as pre-treatment or therapy to mice 
irradiated with a lower dose of gamma-irradiation,
i. e. 4 Gy, which is more realistic for human exposure. 
The effi ciency of the test compounds was evaluated on 
the cellular level by determining leukocyte count and 
cell damage using the alkaline comet assay.
MATERIALS AND METHODS
Chemicals and reagents
Unless specifi ed otherwise, chemicals and reagents 
used were purchased from Sigma Chemical Co., St. 
Louis, MO, USA.
Propolis
In this and our previous studies we used raw 
Croatian propolis. It belongs to the poplar-type of 
propolis, characteristic for the northern hemisphere 
(12). Recent spectrophotometric analyses showed 
that its ethanolic extract contained 84.40 % of total 
polyphenols, of which 1.6 % were flavones and 
fl avonols, 38.60 % fl avanones and dihydrofl avonols, 
and 40.20 % total fl avonoids (10).
The propolis was collected by scraping it off bee 
hive frames. Before use it was kept desiccated at room 
temperature. Ethanolic extract of propolis (EEP) was 
prepared using the method described by Kosalec et 
al. (34). Briefl y, raw propolis (10 g) was crushed into 
small pieces in a mortar and mixed vigorously with 
50 mL of 80 % ethanol at (37±1) °C for 48 h. Eighty-
percent ethanol was prepared by diluting 96 % ethanol 
(Kemika, Croatia) with sterile bidistilled water. The 
mixture of propolis and ethanol was fi ltered through 
Whatman No. 4 paper, lyophilised, and kept in dark 
at +4 °C. 
EEP was injected to mice intraperitoneally (ip) 
at a daily dose of 100 mg kg-1 body weight for three 
consecutive days before (pretreatment) or after 
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irradiation (therapy). The final concentration of 
ethanol in EEP injected to mice was less than or equal 
to 1 %. The same concentration of ethanol was given 
to mice in the solvent control group.
Quercetin
Quercetin dihydrate, -3,3’,4’,5,7-pentahy droxy-
fl avone dihydrate (Fluka, BioChemica, Switzerland) 
was dissolved in ethanol and further dilutions were 
made in sterile bidistilled water. Just like EEP, 
quercetin was also injected to mice at a daily dose of 
100 mg kg-1 body weight for three consecutive days 
before or after irradiation. The fi nal concentration of 
ethanol in quercetin solution injected to mice was less 









S•2HBr) was used as positive 
control, since earlier studies on X-irradiated mice 
verifi ed its capacity to extend the survival rate in the 
dose range of 8 Gy to 11 Gy (35). Before use, it was 
dissolved in sterile bidistiled water and given to mice 
intraperitoneally at a dose of  281 mg kg-1 body weight 
before or after irradiation.
The doses of all compounds were based on the 
positive results of our earlier studies and on reports 
of other authors (10-12, 35-37).
Animals
The study was perfomed on male, three-month-
old CBA mice (N=75) weighing from 20 g to 22 g. 
The animals were kept in Plexiglass® cages under 
controlled conditions [room temperature (22±1) °C, 
50 % to 70 % humidity, 12-h light : 12-h dark cycle], 
received a standard diet for laboratory rodents
(4 RF 21, Mucedola s.r.l., Italy), and had free access to 
water. The mice were randomly distributed in groups 
of fi ve and were deprived of food for 24 h before 
the experiment. Animal studies were carried out in 
accordance with the Croatian Animal Welfare Act 
(38) and the Guide for the Care and Use of Laboratory 
Animals issued by the US Institute for Laboratory 
Animal Research (39).
Experimental design
Three independent experiments were performed. 
In the fi rst, mice were pre-treated with test compounds 
for three consecutive days and then gamma-irradiated 
with a single dose of 4 Gy. In the second experiment, 
mice were fi rst irradiated with a single dose of 4 Gy 
and then received intraperitoneal doses of the tested 
compounds for three consecutive days (therapy). In 
the third experiment, the test compounds were given 
to non-irradiated mice following the same design. 
Appropriate control groups were also selected and 
handled in the same manner. Negative control was 
given saline, solvent control 1 % ethanol, and positive 
control chemical radioprotector AET. All (treated and 
control) groups included fi ve mice each.
In the first experiment, leukocyte count and 
the alkaline comet assay were performed on blood 
samples taken 30 min after irradiation, while in second 
and third experiments blood samples were taken after 
fi nishing the three-day treatment.
Irradiation
Five mice were whole-body irradiated at a time 
using a 60Co gamma-ray source (situated at the 
Ruđer Bošković Institute, Zagreb, Croatia). Source-
to-skin distance was 291 cm, and the dose rate was 
0.0233 Gy s-1. It took 173 s to achieve the total 
absorbed dose of 4 Gy.
METHODS
Collection of blood
Blood samples were drawn from the tail vein and 
processed for analysis immediately after collection.
Peripheral whole blood leukocyte count
Total peripheral blood leukocytes were counted 
using a haemocytometer (40).
The comet assay
The comet assay was carried out under alkaline 
conditions, as described by Singh et al. (41). Two 
slides per animal were prepared. Agarose gels were 
prepared on fully frosted slides coated with 1 % 
and 0.6 % normal melting point (NMP) agarose. 
Samples of peripheral blood (5 µL) were mixed with 
0.5 % low melting point (LMP) agarose, placed on 
the slides, and covered with a layer of 0.5 % LMP 
agarose. The slides were immersed for 2 h in freshly 
prepared ice-cold lysis solution (2.5 mol L-1 NaCl, 
100 mmol L-1 ethylenediamine-tetraacetic acid 
disodium salt (Na
2
EDTA), 10 mmol L-1 Tris-HCl, 1 % 
Na-sarcosinate, pH 10) with 1 % Triton X-100 and 
10 % dimethyl sulfoxide (Kemika, Zagreb, Croatia). 
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Denaturation and electrophoresis were carried out in 
a freshly prepared electrophoresis buffer (300 mmol
L-1 NaOH, 1 mmol L-1 Na
2
EDTA, pH 13.0) at 4 °C 
under dim light. After 20 min of denaturation, the 
slides were randomly placed in the horizontal gel-
electrophoresis tank, facing the anode. Electrophoresis 
at 25 V and 300 mA lasted another 20 min. After 
the electrophoresis, the slides were washed with a 
neutralisation buffer (0.4 mol L-1 Tris-HCl, pH 7.5) 
three times at fi ve-minute intervals. The slides were 
stained with ethidium bromide (20 μg mL-1) and 
examined using a 250x magnifi cation fl uorescence 
microscope (Zeiss, Germany) equipped with an 
excitation fi lter of 515 nm to 560 nm and a barrier fi lter 
of 590 nm. A total of 50 comets per sample per animal 
were scored (25 from each of two replicate slides) and 
pooled for each group of fi ve animals (totalling 250 
per group). Random fi elds were selected at a constant 
depth of the gel, avoiding the edges, and occasional 
dead cells and comets were captured with a black and 
white camera. The microscope image was transferred 
to a computer-based image analysis system (Comet 
Assay II, Perceptive Instruments Ltd. Suffolk, UK) 
and three main comet parameters were evaluated: 
tail length (expressed in micrometers), tail intensity 
(DNA % in the comet tail), and tail moment.
Statistical analysis
For statistical analysis we used Statistica® 7.0 
(StatSoft, Tulsa, USA). Each sample was characterised 
for the extent of DNA damage with the mean (± 
standard error of the mean), median, and range of the 
comet parameters measured. Moreover, cells were 
classifi ed as either “damaged” or “undamaged” in 
respect to the threshold level for a long-tailed nucleus 
(LTN), i.e. the length over the 95th percentile of the 
distribution of the tail lengths among controls (42). 
We used logarithmic transformation to normalise 
the distribution and equalise variances. Multiple 
comparisons between groups were performed on 
log-transformed data using the analysis of variance 
(ANOVA). The chi-square test was used for the 
statistical evaluation of LTN comet frequency. The 
level of statistical signifi cance was set at P<0.05.
RESULTS
Peripheral blood leukocyte count
Total leukocyte counts in mice are reported in 
Figure 1. Animals that were pre-treated with either 
natural and synthetic radioprotectors were less sensitive 
to the adverse effects of whole-body irradiation. Post-
irradiation therapy, however, insignifi cantly increased 
total leukocyte counts compared to negative control.
EEP and quercetin showed an acceptable toxicity 
profi le compared to the synthetic radioprotector AET, 
which caused a drop in total leukocyte count in non-
irradiated mice. This value was signifi cantly lower than 
in non-irradiated mice that received EEP (P=0.048) 
or quercetin (P=0.015). In contrast to AET, EEP and 
quercetin slightly increased the total leukocyte count 
in non-irradiated mice, but these differences were not 
statistically signifi cant (Figure 1).
Overall, quercetin showed better protective 
properties than EEP, both in pre-treatment and in 
therapy, and it also activated a higher number of 
leukocytes in non-irradiated mice.
Primary DNA damage in leukocytes
Figure 2 shows the results of the alkaline comet 
assay expressed as percentage of comets with long 
tailed nuclei (LTN/%). The lowest LTN frequency 
was observed in mice pre-treated with quercetin; 
it differed significantly from all other samples 
(Figure 2). In contrast, pre-treatment with synthetic 
radioprotector AET had the highest LTN frequency. 
As for post-irradiation therapy, LTN frequency was 
similar to negative and solvent controls, save for 
quercetin-treated mice, and ranged as follows: EEP 
< AET < quercetin. None of the tested compounds 
induced a signifi cant increase in LTN frequency in 
non-irradiated mice. Overall, quercetin showed better 
protective properties in pre-treatment, and EEP in 
post-irradiation therapy. On the other hand, AET 
induced a signifi cant increase in primary DNA damage 
when given as pre-tretment, and a slight increase as 
post-irradiation therapy (Figure 2).
Table 1 shows the descriptive statistics and detailed 
inter-group comparisons for the comet tail lengths, 
tail intensities (% tDNA), and tail moments measured 
in mouse leukocytes. Whole-body irradiation with 
4 Gy signifi cantly increased leukocyte primary DNA 
damage in respect to non-irradiated mice. However, 
irradiated mice pre-treated with either EEP or 
quercetin showed lower tail length, tail intensity, 
and tail moment. Quercetin was more effective than 
EEP, and both were less genotoxic than AET. The 
mice given post-irradiation therapy with EEP showed 
a slightly, but not signifi cantly lower primary DNA 
damage than negative controls. In contrast, quercetin 
and AET increased all three comet parameters. In 
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non-irradiated mice, neither EEP nor quercetin were 
genotoxic in concentrations tested. AET, on the other 
hand, caused a slight but not signifi cant increase in all 
three parameters.
DISCUSSION
One of the major challenges in cancer research 
is to discover non-toxic, selective, and effective 
Figure 1  Peripheral blood leukocyte counts (mean ± SE) in CBA mice receiving EEP, quercetin, AET, solvent, or saline 
(negative control) for three consecutive days before or after whole-body irradiation with gamma-rays (4 Gy) and in 
non-irradiated mice receiving the same (pre)treatment.
Note: inter-group comparisons were performed using ANOVA with post-hoc Duncan test. Signifi cantly increased 
values (P<0.05) are: a - compared to mice given quercetin; b - compared to mice given AET; c - compared to solvent 
control; d - compared to negative control; e - compared to mice given EEP.
Figure 2  Results of the alkaline comet assay expressed as percentage of comets with long tailed nuclei (LTN/%) measured in 
peripheral blood leukocytes of CBA mice receiving EEP, quercetin, AET, solvent, or saline (negative control) for 
three consecutive days before or after whole-body irradiation with gamma-rays (4 Gy) and in non-irradiated mice 
receiving the same (pre)treatment. 
Note: inter-group comparisons were performed using the chi-square test. Statistical signifi cance was set at P<0.05. 
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cytoprotective compounds that would preferentially 
protect normal tissues during radiotherapy or 
chemotherapy. These compounds should be effective 
against genetic damage, mutation, changes to the 
immune system, and teratogenic effects.
In this study, we investigated radioprotective 
potentials of two natural compounds that were 
administered to mice before and after whole-body 
irradiation with gamma-rays. Ethanolic extract of 
propolis (EEP) contains a high proportion of bioactive 
lipophilic compounds such as fl avones, fl avonols and 
fl avanones, and is widely used in traditional medicine 
(34). Quercetin is at the moment one of the most 
investigated and biologically effective polyphenols 
(12, 23). Here we report the results obtained with one 
dose of either compound (100 mg kg-1), which was 
based on the positive fi ndings of our previous studies 
(10-12, 27, 31). In future studies we will investigate 
a broader range of doses.
Although exposure to ionising radiation involves 
different types of irradiation, this study focused only 
on adverse effects observed after external exposure 
to gamma-irradiation. Similar to gamma-rays are 
X-rays, and both are classifi ed as highly penetrating. 
X-rays and gamma rays have the same effect on cells. 
X-rays were the fi rst form of photon radiation to be 
used to treat cancer. Nowadays, exposure to X-rays 
is mainly limited to diagnostic medicinal procedures, 
while gamma-rays are mostly used in radiotherapy 
and other more sophisticated methods (43). A typical 
Table 1  Results of the alkaline comet assay expressed as percentage of comets with long tailed nuclei (LTN%) measured in 
peripheral blood leukocytes of CBA mice receiving EEP, quercetin, AET, solvent, or saline (negative control) for three 




Tail length / μm Tail intensity / % tDNA Tail moment
Mean ± SE Median Range
Mean ± 
SE
Median Range Mean ± SE Median Range
Pre-treatment / gamma-irradiation
EEP 16.72±0.20* 16.03 10.90 to 29.49 4.15±0.30 2.53 0 to 33.43 0.52±0.04 0.34 0 to 4.50
Quercetin 15.53±0.18* 14.74 9.62 to 26.92 2.87±0.25* 1.62 0 to 30.05 0.35±0.03* 0.2 0 to 2.70
AET 18.47±0.22 18.27 10.26 to 31.41 3.21±0.22 2.03 0 to 24.41 0.46±0.03 0.31 0 to 3.29
Solvent 
controla
16.92±0.30 15.38 9.62 to 41.02 4.00±0.31 2.25 0 to 30.75 0.54±0.04 0.28 0 to 3.94
Negative 
control
18.57±0.40 16.67 12.18 to 54.49 3.44±0.28 1.99 0 to 35.62 0.49±0.04 0.26 0 to 6.62
Gamma-irradiation / therapy
EEP 17.04±0.36 15.38 10.90 to 44.87 4.08±0.36 1.67 0 to 39.84 0.56±0.05 0.22 0 to 4.90
Quercetin 23.04±0.95* 16.99 10.90 to 85.90 5.93±0.46 3.11 0 to 39.52 0.98±0.09 0.42 0 to 6.60
AET 18.38±0.54 15.38 10.26 to 52.56 4.75±0.50 1.44 0 to 47.40 0.79±0.09 0.19 0 to 8.34
Solvent 
controla
18.26±0.41 16.03 11.54 to 50.00 4.43±0.46 1.75 0 to 48.56 1.37±0.52 0.25 0 to 9.82
Negative 
control
18.01±0.53 15.06 10.26 to 53.85 4.62±0.59 1.34 0 to 49.84 0.78±0.12 0.17 0 to 12.46
Non-irradiated mice
EEP 13.35±0.08 13.46 10.26 to 17.31 1.41±0.17 0.53 0 to 24.18 0.16±0.02 0.07 0 to 2.48
Quercetin 13.75±0.10 13.46 9.62 to 18.59 1.12±0.15 0.30 0 to 24.18 0.13±0.02 0.05 0 to 1.91
AET 14.19±0.14 14.10 9.62 to 22.44 2.18±0.27 0.63 0 to 32.08 0.27±0.03 0.08 0 to 3.70
Solvent 
controla
12.43±0.09 12.50 9.62 to 15.38 1.32±0.26 0.30 0 to 59.54 0.13±0.02 0.04 0 to 3.43
Negative 
control
13.49±0.09 13.46 9.62 to 20.51 1.13±0.15 0.29 0 to 16.24 0.13±0.02 0.04 0 to 1.60
Note: EEP and quercetin were given to mice in ip daily doses of 100 mg kg-1 and AET in ip doses of 281 mg kg-1 body weight. 
aEthanol (1 %); 250 comets per group (50 per animal) were measured; *p<0.05 compared with negative control (ANOVA)
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dose for a solid epithelial tumor may range from 50 Gy 
to 70 Gy or more, given in daily doses that in adults 
usually range from 1.8 Gy to 2 Gy per fraction (44). 
Considering the inter-species differences between mice 
and humans, especially regarding the lethal dose of 
irradiation (45), in this study we selected the radiation 
dose of 4 Gy because affi rmative results with 9 Gy 
prompted us to investigate a dose which corresponds 
more to a real therapeutic dose for humans.
Since mice received whole-body irradiation, the 
genotoxic effects of ionising radiation were studied 
in white blood cells, which circulate throughout 
the body and which have been confi rmed as useful 
biodosimeters by many radiation studies (46, 47). 
The alkaline comet assay was selected as a sensitive 
method for detecting DNA damage in vivo and in vitro 
(ranging from single- and double-strand breaks in 
DNA to DNA base modifi cations, oxidative damage, 
and alkali-labile lesions) produced by known or 
potentially genotoxic substances (48-50).
When interacting with living matter, ionising 
radiation deposits energy that injures or destroys 
cells in the treated area. Absorbed radiation damages 
DNA, making it impossible for cells to grow. Even 
though radiation affects both cancer cells and normal 
cells, the latter can repair themselves and function 
properly. Irradiation in small divided doses allows 
enough time for healthy cells to repair the damage and 
continue to grow. However, cells with a diminished 
ability to repair sub-lethal damage (for example 
undifferentiated cancer cells) and cells with inherited 
or accumulated DNA damage will die or reproduce 
more slowly (44).
Our results demonstrate that acute exposure to 
gamma-irradiation signifi cantly affected the levels 
of primary DNA damage in the leukocytes of CBA 
mice. One of the most important observations is 
that both EEP and quercetin administered to mice 
before whole-body irradiation were more effective in 
reducing primary DNA damage in leukocytes than the 
well-established chemical radioprotector AET (used 
as positive control). Although AET proved effective 
in some studies (35-37), its toxicity/genotoxicity 
seriously questions the reasons for its regular use. 
In contrast, the genotoxicity of EEP and quercetin 
is acceptably low, as evidenced by leukocyte DNA 
damage in non-irradiated mice in our study. We can 
conclude that quercetin is superior as a radioprotector 
when administered as pre-treatment, while EEP 
showed better results when given as therapy. These 
results have been supported by findings of other 
authors. Namely, quercetin itself possesses DNA 
damaging potential and generates free radicals (20, 
23). When given to mice a few days before irradiation, 
it generated oxidative radicals and produced low levels 
of DNA damage, gradually stimulating DNA repair 
mechanisms which in turn counteracted the damage 
infl icted by ionising radiation. Therefore, low doses 
of quercetin potentiate an adaptive response in mice 
leukocytes, making them more resistant to acute 
irradiation. Similar results were reported by Oliveira et 
al. (20), who studied and confi rmed adaptive response 
induced by quercetin in V79 cells in vitro.
In contrast, pre-treatment with EEP, which is a 
mixture of lipophilic compounds with remarkable 
free-radical scavenging properties, was not as effective 
as quercetin. It is possible that, due to complex 
composition, the pro-oxidative properties of quercetin 
are surpressed by other constituents. However, when 
given after irradiation, this complex composition 
contributed to a better recovery of irradiated cells and 
to a more effi cient repair of radiation-infl icted DNA 
damage in mice.
The exact mechanism of protective action of 
propolis and related fl avonoids against lethal effects 
of acute whole-body irradiation in mice is not known. 
Montoro et al. (8) established dose-dependent 
radioprotective effects of a propolis extract against 
DNA damage induced by gamma-radiation doses 
of (0.25 to 5) Gy in vitro. Our study has shown that 
acute exposure to gamma-radiation significantly 
reduces leukocyte count in peripheral blood of mice. 
However, both pre-treatment and therapy with natural 
compounds, especially quercetin, effi ciently protected 
the mice against the adverse effects of ionising 
radiation and also increased leukocyte count in non-
irradiated mice. Several immunomodulators, including 
propolis and propolis-derived components, stimulate 
hemopoietic recovery and enhance the survival of 
irradiated animals (10). Reports of other authors (51, 
52) confi rm the protective effect of propolis on bone 
marrow and lymphoid tissues of mice treated with 
cytotoxic drugs. Immune activity boosted by propolis 
and related compounds enhances haemopoietic 
regeneration and survival following radiation-induced 
lympho- and myelo-supression (10).
In conclusion, our research conducted so far 
suggests that EEP and quercetin are effective and 
non-toxic radioprotectors with a potential to be used in 
supportive therapy in humans, as proposed elsewhere 
(53). However, further research is necessary before 
implementation in human protection against ionising 
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radiation, especially in the treatment of cancer patients 
exposed to radiotherapy.
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Sažetak
PRIMJENA ALKALNOG KOMETNOG TESTA U ISTRAŽIVANJU RADIOPROTEKTIVNIH 
UČINAKA ALKOHOLNOG EKSTRAKTA PROPOLISA I KVERCETINA NA MIŠEVIMA 
OZRAČENIM GAMA-ZRAČENJEM
Na miševima soja CBA istraženi su radioprotektivni učinci alkoholnog ekstrakta propolisa (AEP) i 
fl avonoida kvercetina primijenjenih u obliku predtretmana i terapije usporedo s izlaganjem gama-zračenju 
iz izvora 60Co, doze 4 Gy. Testirane tvari injicirane su miševima intraperitonealno u dozi od 100 mg kg-1 
tijekom tri uzastopna dana. Nakon završetka pokusa u uzorcima krvi ozračenih miševa utvrđen je ukupni 
broj leukocita, a razina primarnih oštećenja u DNA izmjerena je primjenom alkalnog kometnog testa. 
Usporedo su istraženi i mogući genotoksični učinci testiranih tvari na neozračenim miševima. Razine 
radioprotekcije koju pružaju propolis i kvercetin uspoređene su sa sintetskim radioprotektorom AET-om 
(S-(2-aminoetil)izotiouronij bromid hidrobromid). Predtretman miševa bilo kojim oblikom radioprotektora 
pridonosi boljem odgovoru na zračenje. U miševa koji su primili radioprotektore u obliku terapije uočen je 
mali porast ukupnog broja leukocita u odnosu na ozračenu negativnu kontrolu. Kvercetin je pružio bolju 
zaštitu od zračenja nego AEP, i u predtretmanu i terapiji, a u neozračenih miševa potaknuo je oslobađanje 
većeg broja leukocita u odnosu na negativnu kontrolu. Rezultati istraživanja upućuju na to da propolis i 
njegove fl avonoidne sastavnice, osobito ako su primijenjene prije ozračivanja, mogu učinkovito zaštititi 
miševe od štetnih učinaka ionizirajućeg zračenja i smanjiti razinu primarnih oštećenja DNA u leukocitima. 
AEP i kvercetin u testiranim dozama nisu bili genotoksični, za razliku od AET-a koji je izazvao mali 
porast razine oštećenja DNA u leukocitima neozračenih miševa. Iako rezultati istraživanja upućuju na 
radioprotektivne učinke testiranih prirodnih spojeva, radi pojašnjenja pretpostavljenih mehanizama 
radioprotekcije potrebna su daljnja istraživanja.
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